Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the ...

A compelling session at the EHA Congress explored how space research is reshaping our understanding of hematologic processes.

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

The FDA granted fast track designation to nuvisertib for those with intermediate or high-risk myelofibrosis, which ...

Sessions and posters at the 2025 European Hematology Association Congress evaluated the potential and real-world practices of using artificial intelligence (AI) to predict and improve outcomes for ...

One important nutrient that is essential to our general health is vitamin B. But it's possible that a lot of people aren't receiving enough of this vital vitamin, which can cause a number of health ...

The studies evaluated the safety and efficacy of INCA033989 in patients with ET as measured by hematologic response and reduction in mutCALR variant allele frequency (VAF). Results as of April 4, 2025 ...

Adolescent and young adult (AYA) patients with hematological diseases have unique needs that require a multidisciplinary ...

Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...

Experts reassess endpoints, patient selection, targets, and timing for the development of successful immune-based treatments ...

Golidocitinib demonstrated promising efficacy in maintaining and enhancing tumor response in peripheral T-cell lymphoma (PTCL ...

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional ...